Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793118977> ?p ?o ?g. }
- W2793118977 endingPage "14992" @default.
- W2793118977 startingPage "14977" @default.
- W2793118977 abstract "Trib2 pseudokinase has oncogenic and tumour suppressive functions depending on the cellular context. We investigated the ability of Trib2 to transform different haemopoietic stem and progenitor cells (HSPCs). Our study identified the granulocyte-macrophage progenitor (GMP) subpopulation as a potent leukaemia initiating cell of Trib2-driven AML in vivo. Trib2 transformed GMPs generated a fully penetrant and short latency AML. AML cells expressing elevated Trib2 led to a chemoresistant phenotype following chemotherapy treatment. We show that Trib2 overexpression results in an increase in BCL2 expression, and high Trib2 expressing cells are highly sensitive to cell killing by BCL2 inhibition (ABT199). Combined treatment with chemotherapeutic agents and BCL2 inhibition resulted in synergistic killing of Trib2+ AML cells. Trib2 transformed GMP AML cells showed more chemoresistance compared with HSPC derived Trib2 AML cells associated with higher Bcl2 expression. There is significant correlation of high TRIB2 and BCL2 expression in patient derived human AML cells. These data demonstrate that the cell of origin influences the leukaemic profile and chemotherapeutic response of Trib2+ AML. Combined TRIB2 and BCL2 expression in AML cells may have clinical utility relevant for monitoring drug resistance and disease relapse." @default.
- W2793118977 created "2018-03-29" @default.
- W2793118977 creator A5008222285 @default.
- W2793118977 creator A5029863354 @default.
- W2793118977 creator A5043119611 @default.
- W2793118977 creator A5050908023 @default.
- W2793118977 creator A5084024554 @default.
- W2793118977 creator A5087281690 @default.
- W2793118977 creator A5088847091 @default.
- W2793118977 date "2018-02-19" @default.
- W2793118977 modified "2023-10-18" @default.
- W2793118977 title "Trib2 expression in granulocyte-monocyte progenitors drives a highly drug resistant acute myeloid leukaemia linked to elevated Bcl2" @default.
- W2793118977 cites W1552266425 @default.
- W2793118977 cites W1906331108 @default.
- W2793118977 cites W1966822894 @default.
- W2793118977 cites W1967358345 @default.
- W2793118977 cites W1972902934 @default.
- W2793118977 cites W1974351849 @default.
- W2793118977 cites W1977427229 @default.
- W2793118977 cites W1987480626 @default.
- W2793118977 cites W1994041743 @default.
- W2793118977 cites W2000179223 @default.
- W2793118977 cites W2000918094 @default.
- W2793118977 cites W2009886857 @default.
- W2793118977 cites W2021558520 @default.
- W2793118977 cites W2026721712 @default.
- W2793118977 cites W2026990179 @default.
- W2793118977 cites W2027629788 @default.
- W2793118977 cites W2045496844 @default.
- W2793118977 cites W2045662960 @default.
- W2793118977 cites W2046997551 @default.
- W2793118977 cites W2050401495 @default.
- W2793118977 cites W2057444374 @default.
- W2793118977 cites W2061399269 @default.
- W2793118977 cites W2063353266 @default.
- W2793118977 cites W2067792575 @default.
- W2793118977 cites W2071450046 @default.
- W2793118977 cites W2083599915 @default.
- W2793118977 cites W2090757708 @default.
- W2793118977 cites W2090982381 @default.
- W2793118977 cites W2096439168 @default.
- W2793118977 cites W2102461774 @default.
- W2793118977 cites W2109336877 @default.
- W2793118977 cites W2116841124 @default.
- W2793118977 cites W2118037898 @default.
- W2793118977 cites W2119749554 @default.
- W2793118977 cites W2130921299 @default.
- W2793118977 cites W2133904591 @default.
- W2793118977 cites W2159862605 @default.
- W2793118977 cites W2168229622 @default.
- W2793118977 cites W2173150367 @default.
- W2793118977 cites W2178124407 @default.
- W2793118977 cites W2300552754 @default.
- W2793118977 cites W2303094108 @default.
- W2793118977 cites W2333101883 @default.
- W2793118977 cites W2405142225 @default.
- W2793118977 cites W2465625806 @default.
- W2793118977 cites W2475195266 @default.
- W2793118977 cites W2507893670 @default.
- W2793118977 cites W2559634823 @default.
- W2793118977 cites W2594883857 @default.
- W2793118977 cites W2609890161 @default.
- W2793118977 cites W2612676865 @default.
- W2793118977 cites W2724654878 @default.
- W2793118977 cites W2730666287 @default.
- W2793118977 cites W2753475782 @default.
- W2793118977 doi "https://doi.org/10.18632/oncotarget.24525" @default.
- W2793118977 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5871090" @default.
- W2793118977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29599919" @default.
- W2793118977 hasPublicationYear "2018" @default.
- W2793118977 type Work @default.
- W2793118977 sameAs 2793118977 @default.
- W2793118977 citedByCount "16" @default.
- W2793118977 countsByYear W27931189772018 @default.
- W2793118977 countsByYear W27931189772019 @default.
- W2793118977 countsByYear W27931189772020 @default.
- W2793118977 countsByYear W27931189772021 @default.
- W2793118977 countsByYear W27931189772023 @default.
- W2793118977 crossrefType "journal-article" @default.
- W2793118977 hasAuthorship W2793118977A5008222285 @default.
- W2793118977 hasAuthorship W2793118977A5029863354 @default.
- W2793118977 hasAuthorship W2793118977A5043119611 @default.
- W2793118977 hasAuthorship W2793118977A5050908023 @default.
- W2793118977 hasAuthorship W2793118977A5084024554 @default.
- W2793118977 hasAuthorship W2793118977A5087281690 @default.
- W2793118977 hasAuthorship W2793118977A5088847091 @default.
- W2793118977 hasBestOaLocation W27931189771 @default.
- W2793118977 hasConcept C109159458 @default.
- W2793118977 hasConcept C201750760 @default.
- W2793118977 hasConcept C203014093 @default.
- W2793118977 hasConcept C2779282312 @default.
- W2793118977 hasConcept C2781184567 @default.
- W2793118977 hasConcept C28328180 @default.
- W2793118977 hasConcept C502942594 @default.
- W2793118977 hasConcept C54355233 @default.
- W2793118977 hasConcept C81885089 @default.
- W2793118977 hasConcept C86803240 @default.
- W2793118977 hasConcept C95444343 @default.